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Abstract. We present an analysis of the effects of pulsed
electromagnetic fields (PEMF) with 3.3 MHz carrier
frequency and modulated by audio resonant frequencies on
MCF-7 breast cancer cell line in vitro using absorption
spectroscopy. This involves a fluorescence dye called
PrestoBlue™ Cell Viability Reagent and a
spectrophotometry to test the viability of MCF-7 breast
cancer cells under different PEMF treatment conditions in
terms of the cell’s absorption values. The DNA molecule of
the MCF-7 breast cancer cells has an electric dipole
property that renders it sensitive and reactive to applied
electromagnetic fields. Resonant frequencies derived from
four genes mutated in MCF-7 breast cancer cells
[rapamycin-insensitive companion of mammalian target of
rapamycin (RICTOR), peroxisome proliferator-activated
receptor (PPARG), Nijmegen breakage syndrome 1 (NBN)
and checkpoint kinase 2 (CHEK2)] were applied in
generating square pulsed electromagnetic waves. Effects
were monitored through measurement of absorption of the
samples with PrestoBlue™, and the significance of the
treatment was determined using the t-test. There was a
significant effect on MCF-7 cells after treatment with PEMF
at the resonant frequencies of the following genes for specific
durations of exposure: RICTOR for 10 minutes, PPARG for
10 minutes, NBN for 15 minutes, and CHEK2 for 5 minutes.
This research sought to investigate the use of an alternative
approach – pulsed electromagnetic fields – to common breast
cancer treatment protocols as a therapy modality for breast
cancer cells, through the use of breast cancer cell line MCF-
7 (1). The study was in support of a non-invasive, safer,
more affordable, more accessible and more convenient type
of treatment that would be able to achieve acceptable results
in treating breast cancer.
Pulsed electromagnetic fields have already made some
landmark contributions in telecommunications and health
science diagnosis (2). In the early 1960s, the European
Union started to make use of electromagnetic therapeutic
systems for health conditions such as inflamed nerves and
muscles. In some cases, low frequency signals were used to
treat delayed bone fractures (3); these are the types of
fractures that take an exceptionally long time to heal. With
the advent of using low frequency signals, the methodology
eventually developed into what is now termed pulsed
electromagnetic field therapy. Although the name itself has
been reserved for non-cancer treatment, the principle and
physics behind the equipment used are similar to those used
here.
Objective of the study. The objective of the study was to
explore the effects, be it cell proliferation or cell death, of
pulsed electromagnetic fields on the MCF-7 breast cancer cell
line. A cell line is a cell culture developed from a single cell
and therefore consisting of cells with a uniform genetic
makeup. The research applied different treatment parameters,
such as exposure time and specific frequencies, which could
affect either cell proliferation or cell death of MCF-7 breast
cancer cells due to pulsed electromagnetic fields. The
collection of data consisted of a control cell group and a
treated cell group, which were correlated with a standard t-test
to mathematically prove any significant effect. Furthermore,
using absorption spectroscopy, the study was able to analyse
the effects more objectively.
DNA Frequency Theory. The study was based on the DNA
Frequency Theory (4) which contends that the DNA could be
an informational source of frequencies for use in
electrotherapeutic devices. It was found that DNA poses a
dipole characteristic, in which there is directionality of charged
molecules in the chain. If the DNA chain were unravelled, a
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positive charge would be observed on one end of a strand and
a negative charge on the other end. This would mean that DNA
has conducting characteristics. When two strands are bonded
normally, the charges are aligned in parallel but have opposite
polarity. In (5), the polarity of the DNA structure is shown,
where the 5’ to 3’ strand is parallel to the 3’ to 5’ strand. It was
observed that negatively-charged ions pass along the entire
length of the chain in a helical manner. This would surmise that
the strands are sensitive to the effects of electromagnetic fields.
In the realm of radio science, the length of an antenna largely
determines how effective it responds to the wavelength energy
of an incoming transmission. In a similar fashion, it has been
proposed that the length of any piece of DNA could be
resonated using the same principle.
Full details of the DNA Frequency Theory can be found
in (6) where a simple mathematical procedure was proposed
to calculate the frequency of any DNA chain. It indicated
that an organism’s entire DNA genome could possess a
resonant wavelength and frequency related to its total length.
The calculation of the resonant frequency of any DNA was
found to be 4,526,016.22. Thus:
f=4,526,016.22/b Eq. 1
where f=the total resonant frequency and b=# of base pairs
in the DNA chain.
However, some computed frequencies cannot be attained,
due to device limitations. To overcome this, the frequency
can be adjusted to either upper or lower harmonics of the
carrier frequency. This effectively means either doubling the
wavelength or cutting it in half.
MCF-7 Characteristics. MCF-7 is a breast cancer cell line
with a karyotype of 79 to 89 chromosomes (1). It shows
ideal characteristics similar to the mammary epithelium, such
as being receptive to oestrogen and cytokeratin. Since it is
epithelial in form, it has a polygonal shape and a regular
formation. Using karyotyping results from (7), MCF-7
exhibits structural abnormalities of its chromosomes, namely,
X, 1, 2, 3, 5, 6, 7, 8, 9, 12, 13, 15, 18, 19, 20 and 22. In this
study, abnormalities of interest were the following (where p
is the short arm and q is the long arm of the chromosome as
outlined in the ideograms of chromosomes 5 and 8 (8)):
A. addition of material to the short arm (p) of chromosome
5; B. deletion of material from the short arm (p) of
chromosome 3; C. addition of material to the long arm (q)
of chromosome 8; D. deletion of material from the long arm
(q) of chromosome 22.
The rapamycin-insensitive companion of mammalian
target of rapamycin (RICTOR) gene is a part of a protein
complex that encodes for signals involving cell growth (9).
It is located on the short arm of chromosome 5, specifically
on 5p13.1 (10). Since it is at the site of interest given in A,
it may play a role in breast tumour proliferation. This gene
has also been correlated in the formation of smooth muscle
tumours. It has 136,490 base pairs, the number of which will
be essential in calculating the DNA resonant frequency.
The peroxisome proliferator-activated receptor gamma
(PPARG) gene is a protein coding gene (11). It is located on
3p25.2 which is also the site stated in B. The protein
expressed by this gene has been linked to the development
of numerous diseases, such as obesity, diabetes and cancer.
It has 146,989 base pairs.
The Nijmegen breakage syndrome 1 (NBN) gene encodes
for a protein that is associated with the repair of double
strand breaks of DNA (12). It is located on 8q21, which is
exactly at the site of the abnormality stated in C above. An
abnormal NBN gene has been found to cause Nijmegen
breakage syndrome, a condition that causes slow growth in
early childhood. People with this syndrome are shorter than
average and have a higher risk of developing several types
of cancer, including breast cancer (13). This gene has 69,893
base pairs.
The checkpoint kinase 2 (CHEK2) gene, is a tumour
suppressor gene. It is located on 22q12.1, which is exactly
at the site of the abnormality stated in D. An inherited
abnormal CHEK2 gene can cause Li-Fraumeni syndrome, a
condition wherein the patient is susceptible to develop
multiple types of cancer, especially breast cancer (14, 15).
This gene has 54,680 base pairs.
Pulsed electromagnetic field (PEMF). It is known that cells
vibrate or oscillate, and all cells have receptors and other
proteins that can enact change to their activity and metabolic
processes depending on the stimulus. One such stimulus is a
PEMF that utilizes Faraday’s induction law in stimulating
electric current in the target cells. When the PEMF frequency
is carefully tuned to the resonant frequency of target cells, they
respond by generating an electric current produces substantial
heat in the surrounding soft tissues (17). This heat and current
are capable of exerting metabolic changes which affect the
cell’s activities simultaneously. The effects of PEMF can either
benefit or damage the cell (17, 18). When receptor signalling
takes place in the cell by primary messengers (proteins,
hormones, amino acids, enzymes and electromagnetic signals),
the cell changes its behaviour in a prescribed way and it is
directed to perform a certain function, such as the activation of
enzymes or even apoptosis. This study was in support for the
damaging effect of PEMF on cells, specifically breast cancer
cells, and sought to investigate whether DNA can also be
targeted by PEMF, since it is also sensitive to radiation.
Materials and Methods
The methodology was applied in vitro instead of in vivo in order to
minimise any complications that may affect the system under study.
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In order to provide support for the investigation, the in vitro
methodology of preparing the breast cancer cell samples was
modelled using perfusion techniques already prepared by the
Molecular Science Unit of De La Salle University, Philippines. In
essence, the samples used were a replication of the in vivo
phenotype. These samples were equally placed in each well of five
96-microwell plates (8 rows×12 columns) – four for the treatment
group and one for the control group – with 25 μl of cells placed in
each well at approximately 70% confluence. The cells to be treated
with PEMF were placed inside a mesh or Faraday cage that was
targeted by modulating resonant frequency propagated by a 3.3
MHz carrier frequency. To minimise collateral exposure of the
neighbouring samples, aluminium foil was placed on the microwell
plate to cover it, as shown in Figure 1.
There were three exposure times for each target gene: 5, 10 and
15 minutes. One microwell plate served to receive one target gene
resonant frequency. The plate was divided into three to
corresponding with the three different exposure times. For the first
microwell plate, the first four columns were treated with PEMF for
5 minutes using the calculated frequency for the gene. The next four
columns were also targeted using the same resonant frequency, but
the exposure time was 10 minutes. Lastly, the final four columns
were also targeted using the same resonant frequency, but the
duration was 15 minutes. 
The DNA resonant frequencies for the targeted genes in MCF-7
were computed using Eq. 1 from the previous section. These are
outlined in Table I, where the initial values of the computed
frequencies have been increased to the upper harmonics to
overcome device limitations.
The PEMF system used in the experiment is a Beam Ray® brand
supplied by Frequency Technologies LLC with a built-in
radiofrequency amplifier and tuner. PEMF energy is transmitted in
an amplitude-modulated electromagnetic waveform through an
argon-filled plasma tube that serves as an antenna. It typically emits
PEMF in the radiofrequency region oscillating at 3.3 MHz centre
frequency, together with its side harmonics modulated by a square
wave oscillating at audio frequency, ranging from 20 Hz to 20 kHz.
Power output emanating from the plasma tube is about 75
radiofrequency Watts, with an input alternating current electric
power usage around 400-600 Watts, operating at 220V AC. During
operation, the argon-filled plasma tube is placed inside a Faraday
aluminium cage where the microwell plates can be positioned
approximately 2.5 cm below the plasma tube (see Figure 2). Each
experiment was carried out using three microwells at a time in a
plate covered with an aluminium foil. Since there are 96 microwells
in each plate, we performed 32 experiments for every plate under
PEMF exposure.
All microwell plates with PEMF-exposed MCF-7 breast cancer
cells were treated with 25 μl of PrestoBlue™ (also known as
Resazurin) dye, including those of the control group. The dye
changes colour depending on cell viability (19, 20); the initial blue
colour eventually turns into red, purple or pink colour hues,
implying that the cells are still alive. If the colour remains blue, the
cells are no longer viable. A more quantitative method to determine
cell viability is by measuring the absorption values using a
spectrophotometer. Following PrestoBlue™ application, all
microwell plates were incubated at 32˚C for 40 minutes to ensure
proper viability assessment. They were then placed in the
spectrophotometer for absorption reading. The absorption readings
were copied, tabulated and saved electronically.
All samples were exposed under the same laboratory conditions
(i.e. temperature, mixture of solutions and durations of exposure),
therefore the statistical test was used under the assumption of equal
variances. A standard statistical t-test followed, and the level of
confidence was set at 95% to compare the absorption values
between the control and treated groups. Differences between the
control and treated cells were considered significant at p<0.05.
Results and Discussion
The absorption values of the control were used as the
standard. As mentioned above, wells with absorption values
significantly below the controls were considered dead (not
viable), whereas those with values equal or above the controls
were considered viable (alive). The absorption values for
MCF-7 cells treated with RICTOR, PPARG, NBN and CHEK2
gene resonant frequencies are shown in Figure 3.
The results are outlined in Tables II-V for each of the
genes, respectively, where a significant change with respect
to the control meant a decrease in cell viability (cell death)
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Figure 1. A 96-well plate with breast cancer cells being prepared for
exposure to pulsed electromagnetic fields.
Figure 2. The pulsed electromagnetic field system where the Ar-filled
plasma tube is placed inside a Faraday aluminium cage with the
microwell plates 2.5 cm below the plasma tube.
and a negative t-value implied an increase in cell
proliferation.
Figure 3 shows that MCF-7 cell viability decrease after 5
minutes of PEMF exposure with the RICTOR resonant
frequency. The PPARG gene showed an interesting effect of
its resonant frequency. The breast cancer cell absorption
values were significantly lower only after the 10-minute
exposure. Below or beyond this duration there was
insignificant effect on cell viability. This indicates that the
optimal exposure is 10 minutes with the resonant frequency
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Figure 3. Absorption values for cell cultures treated at resonant frequencies of the rapamycin-insensitive companion of mammalian target of
rapamycin (RICTOR) (A), peroxisome proliferator-activated receptor (PPARG) (B), Nijmegen breakage syndrome 1 (NBN) (C) and checkpoint kinase
2 (CHEK2) (D) genes.
Table I. Computed DNA resonant frequencies.
Encoded protein                           No. of DNA                   Computed DNA resonant                    Resonant frequency in                   nth Harmonic
(target gene location)                      base pairs                              frequency (Hz)                              upper harmonics (Hz)
RICTOR (5p13.1)                             136,490                                        33.16                                                2,122.24                                       64th
PPARG (3p25.2)                               146,989                                        30.79                                                1,970.56                                       64th
NBN (8q21)                                        69,893                                         64.76                                                2,072.32                                       32nd
CHEK2 (22q12.1)                              54,680                                         82.77                                                2,648.64                                       32nd
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Table II. Two-sample t-test assuming equal variances for the rapamycin-insensitive companion of mammalian target of rapamycin (RICTOR)  gene.
Significance was accepted at a value of p<0.05.
Exposure duration                                      5 Minutes                                                  10 Minutes                                                  15 Minutes
Variable                                       Control                 Dependent                   Control                     Dependent                     Control                    Dependent
Mean                                          0.606844                 0.620125                   0.624016                   0.5782188                    0.626734                    0.591531
Pooled variance                        0.0048214                                                   0.00039                                                         0.000120                           
Observations                                   32                            32                              32                                32                                32                               32
t Stat                                         −0.540998                                                  6.525117                                                        9.092827                           
p-Value (T≤t) one-tail               0.29625s                                                   1.622E-07                                                      1.996E-10                          
p-Value (T≤t) two-tail               0.592504                                                  3.245E-07                                                      3.993E-10                          
Table III. Two-sample t-test assuming equal variances for the peroxisome proliferator-activated receptor (PPARG) gene. Significance was accepted
at a value of p<0.05.
Exposure duration                                      5 Minutes                                                  10 Minutes                                                  15 Minutes
Variable                                       Control                 Dependent                   Control                     Dependent                     Control                    Dependent
Mean                                          0.606844                 0.603552                   0.624016                    0.602500                     0.626734                    0.624719
Pooled variance                        5.03 E-05                                                   0.000182                                                        0.001553                           
Observations                                   32                            32                              32                                32                                32                               32
t Stat                                          1.312609                                                   4.515842                                                        0.144656                           
p-Value (T≤t) one-tail               0.099634                                                   4.55 E-05                                                        0.442975                           
p-Value (T≤t) two-tail               0.199268                                                   9.10 E-05                                                        0.885950                           
Table IV. Two-sample t-test assuming equal variances for the  Nijmegen breakage syndrome 1 (NBN) gene. Significance was accepted at a value of
p<0.05.
Exposure duration                                      5 Minutes                                                  10 Minutes                                                  15 Minutes
Variable                                       Control                 Dependent                   Control                     Dependent                     Control                    Dependent
Mean                                          0.606844                 0.613406                   0.624016                    0.615312                     0.626734                    0.597203
Pooled variance                         0.000297                                                   0.000148                                                        7.57 E-05                           
Observations                                   32                            32                              32                                32                                32                               32
t Stat                                          -1.077355                                                   2.025462                                                        9.596555                           
p-Value (T≤t) one-tail               0.144954                                                   0.025898                                                        5.91 E-11                           
p-Value (T≤t) two-tail               0.289909                                                   0.051796                                                        1.18 E-10                           
Table V. Two-sample t-test assuming equal variances for the checkpoint kinase 2 (CHEK2)  gene. Significance was accepted at a value of p<0.05.
Exposure duration                                      5 Minutes                                                  10 Minutes                                                  15 Minutes
Variable                                       Control                 Dependent                   Control                     Dependent                     Control                    Dependent
Mean                                           0.60684                  0.591344                   0.624016                    0.595203                     0.626734                    0.517453
Pooled variance                      5.8307 E-05                                                 0.000230                                                        0.000348                           
Observations                                   32                            32                              32                                32                                32                               32
t Stat                                          5.741366                                                   5.376790                                                       16.562768                          
p-Value (T≤t) one-tail              1.43 E-06                                                  4.01 E-06                                                       6.11 E-17                           
p-Value (T≤t) two-tail              2.87 E-06                                                  8.03 E-06                                                       1.22 E-16                           
of the PPARG gene, if the target effect is cell death. Treatment
with the resonant frequency for the NBN gene showed
interesting results. For the 5- and 10-minute durations, there
was no significant effect on cell viability. Remarkably, only
the 15-minute duration significantly reduced cell viability.
Finally, using the resonant frequency for the CHEK2 gene, a
significant reduction of cell viability was shown for all
durations. As the exposure time increased, an inverse
relationship between duration of PEMF exposure at the
CHEK2 resonant frequency with cell viability was established.
The value of this research is based on the premise that, as
medical research advances, gradually increasing specific and
therapeutic modalities emerge from physics, biology and
engineering innovations (e.g. proton therapy, intensity
modulated radiotherapy, radiofrequency therapy, radiation
therapy, and stem cell therapy). In spite of these different
innovations, breast cancer remains the leading cancer
diagnosed in female patients.
The common treatment protocols in breast cancer are
surgery, external beam radiation therapy, chemotherapy,
hormone therapy, targeted therapy, immunotherapy and
bone-directed therapy; most of which have several side-
effects. Even with such advanced methods, some cancer cells
remain resilient and may even lead to metastasis.
Furthermore, many sectors of the population, especially
those in developing countries, have an inadequate level of
healthcare services due to factors affecting their
circumstances, such as financial incapability and lack of
access to quality and affordable medical care (21). As
mentioned previously, we believe that the application of this
approach supports a non-invasive, safer, more affordable,
more accessible and more convenient type of treatment that
would be able to achieve acceptable results in treating breast
cancer.
Conclusion
Four mutated genes in the MCF-7 breast cancer cell line
were targeted and their resonant frequencies computed using
the equation provided by the DNA Frequency Theory. The
frequencies were emitted using a pulsed electromagnetic
field machine that was amplitude-modulated. Targeting of
each gene led to results that indicate the existence of an
optimal exposure time to a specific radiofrequency in order
to reduce cell viability. Although cell proliferation was
observed in a few samples, the t-test proved that these were
insignificant in the overall results. 
Overall, the different frequencies used imply that there is no
relationship between increasing the radiofrequency values and
reduction of cell viability. This is attributed to the fact that the
resonant frequency of 2,072.32 Hz for the NBN gene had a
more significant effect than that for PPARG (1,970.56 Hz),
despite being higher. In other words, there is a specific
frequency that must be used in order for cell viability to be
affected.
In essence, the CHEK2 gene is an ideal target for
producing significant cell death of the MCF-7 breast cancer
cell line. This is as a result of its resonant frequency yielding
most cell death.
For further research, it is recommended that other genes
should be targeted, aside from the ones used here. This is in
order to observe whether more effective resonant frequencies
could be used. It is also recommended to use different
harmonics of resonant frequencies to identify any significant
changes in cell viability. Each resonant frequency has
different effects on MCF-7 breast cancer cells, at different
exposure times, which necessitates further analysis using a
genotoxicity test. This will result in a better understanding
of the different mechanisms involved in more effectively
debilitating MCF-7 breast cancer cells.
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